New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

T O'Hare, CA Eide, MW Deininger - Expert opinion on …, 2008 - Taylor & Francis
Targeted therapy with the Abl kinase inhibitor imatinib has markedly improved the outlook
for patients with chronic myeloid leukemia (CML). Breakpoint cluster region (Bcr)-Abl …
被引用次数：76 相关文章

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check.

T O'Hare, CA Eide, MW Deininger - Expert Opinion on …, 2008 - europepmc.org
Targeted therapy with the Abl kinase inhibitor imatinib has markedly improved the outlook
for patients with chronic myeloid leukemia (CML). Breakpoint cluster region (Bcr)-Abl …

[引用][C] New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

T O'HARE - Export Opin Investig Drugs, 2008 - cir.nii.ac.jp

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

T O'Hare, CA Eide… - Expert opinion on …, 2008 - pubmed.ncbi.nlm.nih.gov
Targeted therapy with the Abl kinase inhibitor imatinib has markedly improved the outlook
for patients with chronic myeloid leukemia (CML). Breakpoint cluster region (Bcr)-Abl …